Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
| Revenue (TTM) | $3.46B |
| Gross Profit (TTM) | $2.59B |
| EBITDA | $1.08B |
| Operating Margin | 29.60% |
| Return on Equity | 14.40% |
| Return on Assets | 7.58% |
| Revenue/Share (TTM) | $21.15 |
| Book Value | $44.83 |
| Price-to-Book | 6.20 |
| Price-to-Sales (TTM) | 12.88 |
| EV/Revenue | 11.26 |
| EV/EBITDA | 36.22 |
| Quarterly Earnings Growth (YoY) | 39.50% |
| Quarterly Revenue Growth (YoY) | 17.60% |
| Shares Outstanding | $161.91M |
| Float | $148.29M |
| % Insiders | 8.61% |
| % Institutions | 93.63% |
Volatility is currently expanding
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Veeva raises its fiscal 2027 outlook as Vault CRM adoption, R&D growth and Falcon AI momentum support expanding revenue and profitability.
VEEV's strong Q2 results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.
PLEASANTON, Calif., Sept. 1, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Falcon Safety, an agentic safety operations product to streamline adverse event intake, case processing, and follow-up to reduce costs, increase speed, and maintain compliance for biopharma companies of all sizes.
Veeva Systems Inc. delivered accelerating revenue growth to 18% in Q2/27, surpassing guidance and analyst expectations. VEEV's aggressive $2B buyback program is offsetting SBC, reducing share count, and supporting EPS growth; $1.4B remains for future repurchases. The balance sheet is robust with $1.8B cash, $5.4B short-term investments, and minimal debt, providing downside protection.
VEEV's Q2 fiscal 2027 earnings and revenues top estimates, while strong Vault CRM momentum and a raised full-year outlook drive shares higher.
Veeva spotlights Falcon AI demand and record Vault CRM execution as stronger Q2 results support higher fiscal 2027 guidance.
Veeva Systems is rated a buy, supported by durable double-digit revenue growth, expanding profitability, and a robust, debt-light balance sheet. VEEV's recurring subscription model drives high margins—Q1 FY2027 saw 75% GAAP gross margin and 86.4% subscription gross margin, with continued product adoption fueling growth. Management raised FY2027 guidance and targets a $6 billion revenue run rate by 2030, with Q2 revenue expected to exceed guidance.
Veeva Systems Inc. (VEEV) Q2 2027 Earnings Call Transcript
Total Revenues of $928.0M, up 18% Year Over Year Subscription Revenues of $766.8M, up 16% Year Over Year PLEASANTON, Calif., Aug. 26, 2026 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on VEEV and any ticker you trade — then tracks every position and per-strategy win rate.
